Top compounds associated with response to PARK2


Feature Type Standardized
Nominal ANOVA
mRNA paclitaxel gCSI pan-cancer AAC -0.15 0.003
mRNA PD-0332991 CCLE pan-cancer AAC 0.14 0.004
mRNA procarbazine CTRPv2 pan-cancer AAC 0.11 0.004
mRNA Cytarabine GDSC1000 pan-cancer AAC -0.1 0.004
mRNA CI-976 CTRPv2 pan-cancer AAC 0.11 0.004
mRNA thapsigargin gCSI pan-cancer AAC -0.16 0.004
mRNA AS601245 GDSC1000 pan-cancer AAC -0.096 0.006
mRNA Ko-143 CTRPv2 pan-cancer AAC -0.1 0.006
mRNA MP470 GDSC1000 pan-cancer AAC 0.094 0.006
mRNA Docetaxel gCSI pan-cancer AAC -0.14 0.006
Download CSV